Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
Everything you need to know about Dayvigo (lemborexant) and anesthesia interactions, including when to hold the dose, what to tell your anesthesiologist, and how alcohol fits into this picture.
Read clinical reviewA clinical guide to the Dayvigo (lemborexant) and imaging contrast dye interaction, covering sedation risk, CNS depression, alcohol use, and how to time your dose around an MRI or CT scan.
Read clinical reviewA clinical review of the Dayvigo (lemborexant) and alcohol interaction, covering pharmacodynamic combination, CNS depression risk, trial data, and prescriber guidance.
Read clinical reviewA detailed clinical review of the lemborexant (Dayvigo) and cannabis drug interaction, including CNS depression risks, pharmacokinetic mechanisms, alcohol combinations, and dosing guidance from the FDA label and primary literature.
Read clinical reviewA clinical review of the lemborexant (Dayvigo) and nicotine interaction, including CYP3A4 metabolism overlap, alcohol co-use risk, and prescriber guidance for patients who smoke or use nicotine replacement therapy.
Read clinical reviewA clinically detailed review of lemborexant (Dayvigo) and its interaction profile with vaccines, alcohol, and other drugs, with primary-source citations.
Read clinical review